160 related articles for article (PubMed ID: 3032483)
1. Peripheral neuropathy with gammopathy responding to plasmapheresis.
Frayne J; Stark RJ
Clin Exp Neurol; 1985; 21():195-200. PubMed ID: 3032483
[TBL] [Abstract][Full Text] [Related]
2. AAEE case report #17: Peripheral neuropathy in monoclonal gammopathy of undetermined significance.
Donofrio PD; Kelly JJ
Muscle Nerve; 1989 Jan; 12(1):1-8. PubMed ID: 2546074
[TBL] [Abstract][Full Text] [Related]
3. Use of plasmapheresis and chemotherapy for treatment of monoclonal gammopathy associated with Ehrlichia canis infection in a dog.
Matus RE; Leifer CE; Hurvitz AI
J Am Vet Med Assoc; 1987 May; 190(10):1302-4. PubMed ID: 3583884
[TBL] [Abstract][Full Text] [Related]
4. Autologous peripheral blood stem cell transplantation for peripheral neuropathy secondary to monoclonal gammopathy of unknown significance.
Lee YC; Came N; Schwarer A; Day B
Bone Marrow Transplant; 2002 Jul; 30(1):53-6. PubMed ID: 12105779
[TBL] [Abstract][Full Text] [Related]
5. [Neurological manifestations of monoclonal gammopathies].
Chassande B; Léger JM
Rev Prat; 1993 Feb; 43(3):314-6. PubMed ID: 8389055
[TBL] [Abstract][Full Text] [Related]
6. [Neurophysiologic, morphologic and immunologic study of nerves in 2 cases of chronic polyneuropathy in IgM gammopathy].
Gambaro P; Bottacchi E; Nemni R; Corbo M; Camerlingo M; Mamoli A
Riv Neurobiol; 1984; 30(2-3):249-60. PubMed ID: 6100515
[No Abstract] [Full Text] [Related]
7. [Successful treatment with rituximab in two cases of IgM-monoclonal gammopathy of undetermined significance (MGUS) neuropathy].
Koike M; Sugimoto K; Tusui M; Yahata Y
Rinsho Ketsueki; 2012 Apr; 53(4):450-4. PubMed ID: 22687979
[TBL] [Abstract][Full Text] [Related]
8. Selective techniques of apheresis in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
Siciliano G; Moriconi L; Gianni G; Richieri E; Vignocchi MG; Rossi B
Acta Neurol Scand; 1994 Feb; 89(2):117-22. PubMed ID: 8191874
[TBL] [Abstract][Full Text] [Related]
9. [Peripheral neuropathy related to benign monoclonal gammopathy. Treatment with high-dose intravenous human immunoglobins].
Ferroir JP; Fève A; Fénelon G; Stankoff B; Khalil A; Nicolle MH; Guillard A
Ann Med Interne (Paris); 1993; 144(7):496-8. PubMed ID: 8141522
[No Abstract] [Full Text] [Related]
10. Evidence of central nervous system involvement in chronic demyelinating neuropathies associated with "benign" gammopathies.
Provinciali L; Di Bella P; Logullo F; Vesprini L; Pasquini U; Scarpelli M
Riv Neurol; 1989; 59(1):36-44. PubMed ID: 2548277
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management.
Chaudhry HM; Mauermann ML; Rajkumar SV
Mayo Clin Proc; 2017 May; 92(5):838-850. PubMed ID: 28473042
[TBL] [Abstract][Full Text] [Related]
12. Angiofollicular lymph node hyperplasia and peripheral neuropathy. Case report and literature review.
Scherokman B; Vukelja SJ; May E
Arch Intern Med; 1991 Apr; 151(4):789-90. PubMed ID: 1849398
[TBL] [Abstract][Full Text] [Related]
13. The electrodiagnostic findings in peripheral neuropathy associated with monoclonal gammopathy.
Kelly JJ
Muscle Nerve; 1983 Sep; 6(7):504-9. PubMed ID: 6314134
[TBL] [Abstract][Full Text] [Related]
14. Anti-neurofilament antibodies in neuropathy with monoclonal gammopathy of undetermined significance produce experimental motor nerve conduction block.
Stubbs EB; Lawlor MW; Richards MP; Siddiqui K; Fisher MA; Bhoopalam N; Siegel GJ
Acta Neuropathol; 2003 Feb; 105(2):109-16. PubMed ID: 12536221
[TBL] [Abstract][Full Text] [Related]
15. [Chronic capillary hyperpermeability and monoclonal gammopathy].
Lagrue G; Rahbar K; Behar A; Laurent J; Sobel A
Ann Med Interne (Paris); 1987; 138(7):558-9. PubMed ID: 3439680
[No Abstract] [Full Text] [Related]
16. IgA monoclonal gammopathy of undetermined significance with peripheral neuropathy.
Mehndiratta MM; Sen K; Tatke M; Bajaj BK
J Neurol Sci; 2004 Jun; 221(1-2):99-104. PubMed ID: 15178222
[TBL] [Abstract][Full Text] [Related]
17. [Peripheral neuropathies simulating amyotrophic lateral sclerosis in gammopathies].
Bady B; Vial C; Brudon F; Lapras J; Kopp N; Trillet M
Rev Neurol (Paris); 1988; 144(11):710-5. PubMed ID: 3231959
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal gammopathy of undetermined significance: a consensus statement.
Berenson JR; Anderson KC; Audell RA; Boccia RV; Coleman M; Dimopoulos MA; Drake MT; Fonseca R; Harousseau JL; Joshua D; Lonial S; Niesvizky R; Palumbo A; Roodman GD; San-Miguel JF; Singhal S; Weber DM; Zangari M; Wirtschafter E; Yellin O; Kyle RA
Br J Haematol; 2010 Jul; 150(1):28-38. PubMed ID: 20507313
[TBL] [Abstract][Full Text] [Related]
19. [Polyneuropathies and monoclonal gammopathies, so-called benign].
Vallat JM; Jauberteau MO; Arbo-Oze-de-Morvil C; Tabaraud F
Rev Prat; 1992 Jan; 42(1):43-5. PubMed ID: 1314413
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical and neurophysiological follow-up of patients with peripheral, neuropathy associated with benign monoclonal gammopathy.
Ponsford S; Willison H; Veitch J; Morris R; Thomas PK
Muscle Nerve; 2000 Feb; 23(2):164-74. PubMed ID: 10639606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
